Yanqing Wu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 3
-
- Cancer-related gene regulation 4
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Cancer-related Molecular Pathways 2
-
- Advanced Breast Cancer Therapies 1
In The Last Decade
Yanqing Wu
16 papers receiving 569 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 318
- Molecular Biology 428
- Hepatology 46
- Oncology 111
- Pathology and Forensic Medicine 46
Countries citing papers authored by Yanqing Wu
This map shows the geographic impact of Yanqing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqing Wu more than expected).
Fields of papers citing papers by Yanqing Wu
This network shows the impact of papers produced by Yanqing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqing Wu. The network helps show where Yanqing Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanqing Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2021 | 51 | |
| 5 | 2020 | 149 | |
| 6 | 2018 | 110 | |
| 7 | Up-regulation of Wnt7b rather than Wnt1, Wnt7a, and Wnt9a indicates poor prognosis in breast cancer. | 2018 | 19 |
| 8 | 2017 | 2 | |
| 9 | 2017 | 77 | |
| 10 | 2017 | 15 | |
| 11 | Up-regulation of the tumor promoter Glyoxalase-1 indicates poor prognosis in breast cancer. | 2017 | 13 |
| 12 | 2017 | 32 | |
| 13 | 2015 | 78 | |
| 14 | 2015 | 3 | |
| 15 | 2015 | 19 | |
| 16 | 2011 | 1 |
About Yanqing Wu
Yanqing Wu is a scholar working on Cancer Research, Developmental Neuroscience and Anesthesiology and Pain Medicine, having authored 16 papers that have together received 572 indexed citations. Recurring topics across this work include Cancer-related gene regulation (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA Research and Splicing (3 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Cancer-related Molecular Pathways (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Cancer Research (318 citations), Molecular Biology (428 citations) and Hepatology (46 citations). Yanqing Wu has collaborated with scholars based in China and Israel. Frequent co-authors include Yujie Liu, Shunying Li, Qianfeng Shi, Yinghua Zhu, Qiang Liu, Junjun Chu, Liang Jin, Erwei Song, Qian Li and Ying Li. Their work appears in journals such as Nature Communications, Heart and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.